Table 1 Drug development costs (Bogdan and Villiger 2010)
Phase | Cost |
|---|---|
Lead optimisation | US$ 2–3 mn |
Preclinical phase | US$ 2–3 mn |
Clinical phase 1 | US$ 1–5 mn |
Clinical phase 2 | US$ 3–11 mn |
Clinical phase 3 | US$ 10–60 mn |
Approval | US$ 2–4 mn |
Phase | Cost |
|---|---|
Lead optimisation | US$ 2–3 mn |
Preclinical phase | US$ 2–3 mn |
Clinical phase 1 | US$ 1–5 mn |
Clinical phase 2 | US$ 3–11 mn |
Clinical phase 3 | US$ 10–60 mn |
Approval | US$ 2–4 mn |